Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2021 07:30 ET | Source: Generation Bio Co.

Generation Bio Appoints Ron Cooper to Its Board of Directors

CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, announced today that Ron Cooper...
January 11, 2021 17:43 ET | Source: Generation Bio Co.

Generation Bio Announces Closing of Public Offering

CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the...
January 06, 2021 21:24 ET | Source: Generation Bio Co.

Generation Bio Announces Pricing of Public Offering

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the pricing of a...
January 05, 2021 06:30 ET | Source: Generation Bio Co.

Generation Bio to Present at 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
January 04, 2021 06:30 ET | Source: Generation Bio Co.

Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates

Data confirm delivery of closed-ended DNA to the liver via novel, cell-targeted lipid nanoparticles Well tolerated at all dose levels in mice and non-human primates Company on track to select...
November 10, 2020 06:30 ET | Source: Generation Bio Co.

Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results

CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene therapy. Today the company...
October 05, 2020 06:30 ET | Source: Generation Bio Co.

Generation Bio to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
September 24, 2020 06:30 ET | Source: Generation Bio Co.

Generation Bio to Present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit

CAMBRIDGE, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
August 11, 2020 06:30 ET | Source: Generation Bio Co.

Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today reported recent...
August 05, 2020 06:30 ET | Source: Generation Bio Co.

Generation Bio to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference

CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that...